Viewing Study NCT00958256

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:28 PM
Ignite Modification Date: 2026-02-01 @ 5:52 PM
Study NCT ID: NCT00958256
Status: COMPLETED
Last Update Posted: 2015-04-13
First Post: 2009-08-11
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of Bortezomib in Combination With Cyclophosphamide and Rituximab
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Mantle Cell Lymphoma View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Mantle Cell Lymphoma View
None Lymphoma View
None Bortezomib View
None Velcade View
None Rituximab View
None Rituxan View
None Cyclophosphamide View
None Cytoxan View
None Neosar View
None Mesna View
None Mesnex View
None G-CSF View
None Filgrastim View
None Neupogen View